【Description】
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
Market Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Gastrointestinal Therapeutics and Diagnostics estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2029, growing at a CAGR of % during the forecast period 2023-2029.
North American market for Gastrointestinal Therapeutics and Diagnostics was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gastrointestinal Therapeutics and Diagnostics was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Europe market for Gastrointestinal Therapeutics and Diagnostics was valued at $ million in 2022 and will reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Therapeutics and Diagnostics.
The Gastrointestinal Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gastrointestinal Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products type, application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Therapeutics and Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
Market Segmentation
This report covers the Gastrointestinal Therapeutics and Diagnostics segments by company, type, application, by region and country, and provides market size and CAGR for the history and forecast period (2018-2023, 2024-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
By Company
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gastrointestinal Therapeutics and Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
【Table of Contents】
1 Market Overview of Gastrointestinal Therapeutics and Diagnostics
1.1 Gastrointestinal Therapeutics and Diagnostics Market Overview
1.1.1 Gastrointestinal Therapeutics and Diagnostics Product Scope
1.1.2 Gastrointestinal Therapeutics and Diagnostics Market Status and Outlook
1.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2029)
1.4 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.4 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029)
2 Gastrointestinal Therapeutics and Diagnostics Market Overview by Type
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Type (2018-2023)
2.3 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029)
2.4 Diagnostics
2.5 Therapeutics
3 Gastrointestinal Therapeutics and Diagnostics Market Overview by Application
3.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2 Global Gastrointestinal Therapeutics and Diagnostics Historic Market Size by Application (2018-2023)
3.3 Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029)
3.4 Gastroenteritis
3.5 GI Bleeding
3.6 Irritable Bowel Syndrome
3.7 Peptic Ulcer Disease (PUD)
3.8 Others
4 Gastrointestinal Therapeutics and Diagnostics Competition Analysis by Players
4.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2022)
4.3 Date of Key Players Enter into Gastrointestinal Therapeutics and Diagnostics Market
4.4 Global Top Players Gastrointestinal Therapeutics and Diagnostics Headquarters and Area Served
4.5 Key Players Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Gastrointestinal Therapeutics and Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.2.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Eisai
5.3.1 Eisai Profile
5.3.2 Eisai Main Business
5.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.3.4 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.4.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Salix Pharmaceuticals
5.5.1 Salix Pharmaceuticals Profile
5.5.2 Salix Pharmaceuticals Main Business
5.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Salix Pharmaceuticals Recent Developments
5.6 Takeda Pharmaceutical Company
5.6.1 Takeda Pharmaceutical Company Profile
5.6.2 Takeda Pharmaceutical Company Main Business
5.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
5.6.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Takeda Pharmaceutical Company Recent Developments
6 North America
6.1 North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gastrointestinal Therapeutics and Diagnostics Market Dynamics
11.1 Gastrointestinal Therapeutics and Diagnostics Industry Trends
11.2 Gastrointestinal Therapeutics and Diagnostics Market Drivers
11.3 Gastrointestinal Therapeutics and Diagnostics Market Challenges
11.4 Gastrointestinal Therapeutics and Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
【Table of Figures】
List of Tables
Table 1. Global Market Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Region (2018-2023)
Table 4. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2018-2023)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Type (2024-2029)
Table 11. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 12. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 13. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2018-2023)
Table 14. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 15. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Application (2024-2029)
Table 16. Global Gastrointestinal Therapeutics and Diagnostics Revenue (US$ Million) by Players (2018-2023)
Table 17. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2018-2023)
Table 18. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics and Diagnostics as of 2022)
Table 19. Date of Key Players Enter into Gastrointestinal Therapeutics and Diagnostics Market
Table 20. Global Gastrointestinal Therapeutics and Diagnostics Key Players Headquarters and Area Served
Table 21. Gastrointestinal Therapeutics and Diagnostics Product Solution and Service
Table 22. Global Gastrointestinal Therapeutics and Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Abbott Laboratories Basic Information List
Table 25. Abbott Laboratories Description and Business Overview
Table 26. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 27. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Abbott Laboratories (2018-2023)
Table 28. Abbott Laboratories Recent Developments
Table 29. AstraZeneca Basic Information List
Table 30. AstraZeneca Description and Business Overview
Table 31. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 32. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of AstraZeneca (2018-2023)
Table 33. AstraZeneca Recent Developments
Table 34. Eisai Basic Information List
Table 35. Eisai Description and Business Overview
Table 36. Eisai Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 37. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Eisai (2018-2023)
Table 38. Eisai Recent Developments
Table 39. Johnson & Johnson Basic Information List
Table 40. Johnson & Johnson Description and Business Overview
Table 41. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 42. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Johnson & Johnson (2018-2023)
Table 43. Johnson & Johnson Recent Developments
Table 44. Salix Pharmaceuticals Basic Information List
Table 45. Salix Pharmaceuticals Description and Business Overview
Table 46. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Salix Pharmaceuticals (2018-2023)
Table 48. Salix Pharmaceuticals Recent Developments
Table 49. Takeda Pharmaceutical Company Basic Information List
Table 50. Takeda Pharmaceutical Company Description and Business Overview
Table 51. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Gastrointestinal Therapeutics and Diagnostics Business of Takeda Pharmaceutical Company (2018-2023)
Table 53. Takeda Pharmaceutical Company Recent Developments
Table 54. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 55. North America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 56. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 57. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 58. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 60. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 61. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2023)
Table 62. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2024-2029)
Table 63. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 64. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 66. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 68. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 69. Gastrointestinal Therapeutics and Diagnostics Market Trends
Table 70. Gastrointestinal Therapeutics and Diagnostics Market Drivers
Table 71. Gastrointestinal Therapeutics and Diagnostics Market Challenges
Table 72. Gastrointestinal Therapeutics and Diagnostics Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Therapeutics and Diagnostics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Gastrointestinal Therapeutics and Diagnostics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Market Share by Regions: 2022 VS 2029
Figure 4. Global Gastrointestinal Therapeutics and Diagnostics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Type in 2022 & 2029
Figure 11. Diagnostics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Therapeutics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market Size Share by Application in 2022 & 2029
Figure 14. Gastroenteritis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 15. GI Bleeding Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Irritable Bowel Syndrome Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 17. Peptic Ulcer Disease (PUD) Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 19. Gastrointestinal Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Top 5 and Top 10 Players Gastrointestinal Therapeutics and Diagnostics Market Share in 2022
Figure 21. North America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 22. U.S. Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 23. Canada Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 24. Germany Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 25. France Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 26. U.K. Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 27. Italy Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 28. Russia Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gastrointestinal Therapeutics and Diagnostics Market Share by Region (2018-2029)
Figure 31. China Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 32. Japan Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 33. South Korea Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 35. India Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 36. Australia Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 37. Latin America Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 38. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 39. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Share by Country (2018-2029)
Figure 41. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 42. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 43. UAE Gastrointestinal Therapeutics and Diagnostics Market Size (2018-2029) & (US$ Million)
Figure 44. Bottom-up and Top-down Approaches for This Report